相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Does belatacept improve outcomes for kidney transplant recipients? A systematic review
Nishanthi Talawila et al.
TRANSPLANT INTERNATIONAL (2015)
CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement
Chun Jing Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
OPTN/SRTR 2012 Annual Data Report: kidney
A. J. Matas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Kidney transplantation outcomes from expanded criteria donors, standard criteria donors or living donors older than 60 years
Sophia Lionaki et al.
RENAL FAILURE (2014)
Factors influencing long-term outcome after kidney transplantation
Christophe Legendre et al.
TRANSPLANT INTERNATIONAL (2014)
Long-Term Outcomes of Kidney Transplantation From Expanded Criteria Deceased Donors at a Single Center: Comparison With Standard Criteria Deceased Donors
J. K. Hwang et al.
TRANSPLANTATION PROCEEDINGS (2014)
Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys
B. Charpentier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
The Predictive Value of Kidney Allograft Baseline Biopsies for Long-Term Graft Survival
Katrien De Vusser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
J. Sellares et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
C. Wiebe et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Summary of the US FDA Approval of Belatacept
P. Archdeacon et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Three-Year Outcomes From BENEFIT-EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys
J. O. M. Pestana et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes
Sumit Mohan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Belatacept: from rational design to clinical application
Thomas Wekerle et al.
TRANSPLANT INTERNATIONAL (2012)
Cardiovascular Risk in Recipients With Kidney Transplants From Expanded Criteria Donors
L. Blanca et al.
TRANSPLANTATION PROCEEDINGS (2012)
Kidney and Pancreas Transplantation in the United States, 1999-2008: The Changing Face of Living Donation
D. A. Axelrod et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT-EXT Study)
A. Durrbach et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
H. Tedesco Silva et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Optimal immunosuppression to prevent chronic allograft dysfunction
Josep M. Grinyo et al.
KIDNEY INTERNATIONAL (2010)
De Novo Donor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure
L. G. Hidalgo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
G. Einecke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Outcomes of Transplantation Using Kidneys From Donors Meeting Expanded Criteria in Australia and New Zealand, 1991 to 2005
Michael G. Collins et al.
TRANSPLANTATION (2009)
Lengthy Cold Ischemia Time Is a Modifiable Risk Factor Associated With Low Glomerular Filtration Rates in Expanded Criteria Donor Kidney Transplant Recipients
C. C. Goh et al.
TRANSPLANTATION PROCEEDINGS (2009)
Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs
R. F. Saidi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Renal transplantation in high-risk patients
Nicole A. Weimert et al.
DRUGS (2007)
Expanded criteria donors for kidney transplantation:: Quality control and results
M. A. Frutos et al.
TRANSPLANTATION PROCEEDINGS (2006)
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-lg with potent immunosuppressive properties
CP Larsen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Immunosuppressive drugs for kidney transplantation
PF Halloran
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome
JE Worthington et al.
TRANSPLANTATION (2003)
Expanded criteria donors for kidney transplantation
RA Metzger et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors
FK Port et al.
TRANSPLANTATION (2002)
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
BD Kahan
LANCET (2000)
分享论文
